← Research LibraryThe BriefFY2025 10-K · headline figures audited against SEC data
Brighthouse grew revenue, net income, and equity, while repurchases slowed and insurance-market risks remain central.
The read at a glance✓ Audited against SEC data
- Business mix — U.S. annuity and life insurance providerNote
- Revenue — $6.77B, up 43.2%OK
- Income — Net income up 11.6%OK
- Equity — Equity up 36.5%OK
- Buybacks — Repurchases down 59.2%Watch
- Insiders — 0 purchases / 0 salesNote
- Accounting — Altman-Z, Beneish-M, and earnings-quality unavailableNote
Business
Brighthouse Financial is a U.S. annuity and life insurance provider with Annuities, Life, Run-off, and Corporate & Other segments.
Where the revenue comes from
Fiscal 2025, as Brighthouse Financial, Inc. reports it. History and quarterly detail are in the app.
- Annuities$3.6B
- Run-off$1.3B
- Life$1.1B
- Corporate Segment and Other Operating$705.0M
Leadership changes
From Brighthouse Financial, Inc.'s own filings, the day they're filed.
- Melissa Pavlovich · Chief Accounting Officer · appointmenteff. 2025-08-30
- Richard Cook · CAO · appointmenteff. 2025-08-30
- Myles J. Lambert · President · appointmenteff. 2025-08-30
Latest filings
- 8-K · Company announcement2026-08-18
- 10-Q · Quarterly report2026-08-06
- 8-K · Company announcement2026-08-05
- 8-K · Company announcement2026-06-03
- 10-Q · Quarterly report2026-05-07
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- Main tension🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about Brighthouse Financial, Inc., every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.